-
In section: UMass Chan News
In subsection: Articles
GSBS speaker to study neurodegenerative disease - UMass Medical School - Worcester
GSBS speaker to study neurodegenerative disease
Bryan Goodchild
UMass Medical School Communications
In this video profile, Graduate School of Biomedical Sciences Class Speaker Jeannette Osterloh explains what her education at UMass Medical School means for her and where she’s headed next.
In this video profile, Graduate School of Biomedical Sciences Class Speaker Jeannette Osterloh explains what her education at UMass
Last modified: Dec 14, 2013
-
In section: UMass Chan News
In subsection: Articles
Envisioning a cure in rare lung disease - UMass Medical School - Worcester
Envisioning a cure in rare lung disease
Researchers, families to focus on potential new treatments in Alpha-1 Antitrypsin Deficiency
Malorye Branca
UMass Medical School Communications
Past milestones and future treatment prospects will be described by world-renowned Alpha-1 researchers at a free program at UMMS on Saturday, April 20.
Past milestones and future treatment prospects will be described by world-renowned Alpha-1
Last modified: Feb 26, 2014
-
In section: UMass Chan News
In subsection: Articles
Two UMass Medical School researchers report on promising new developments in the quest for a treatment for Huntington’s disease in the Thursday, Nov. 1, issue of the New England Journal of Medicine. Neil Aronin, MD, and Melissa J. Moore, PhD, co-authored an editorial on the latest research into Huntington’s disease, an inherited neurological disorder caused by a mutation on a single chromosome.
Last modified: Dec 19, 2013
-
In section: UMass Chan News
In subsection: Articles
Three UMMS students traveled to Bolivia for an infectious disease rotation, treating cases considered exotic in the U.S.
Last modified: Dec 22, 2013
-
In section: UMass Chan News
In subsection: Articles
Spring is here, and with warmer weather comes increased risk for contracting Lyme disease from a deer tick bite. In this Expert’s Corner video, Mark Klempner, MD, discusses the rising incidence of Lyme disease and how individuals can protect themselves.
Last modified: May 21, 2014
-
In section: UMass Chan News
In subsection: Articles
UMass Medical School infectious disease expert Mark Klempner gave a State House briefing on the development of a new medicine to protect against Lyme disease.
Last modified: Jul 21, 2017
-
In section: UMass Chan News
In subsection: Articles
Rare genetic disease protects against bipolar disorder
Rare genetic disease protects against bipolar disorder
UMass Chan researchers uncover genetic pathway that could lead to better treatments
Jim Fessenden
UMass Medical School Communications
A team of scientists led by researchers at the UMass Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar disorder, a breakthrough that could lead to better drugs for treating
Last modified: Oct 14, 2014
-
In section: UMass Chan News
In subsection: Articles
An interdisciplinary panel of Alzheimer’s experts from UMass Medical School will discuss this topic at the next Be Mentally Well talk, “Managing the Impact of Alzheimer’s Disease,” on Wednesday, March 28.
Last modified: Feb 28, 2014
-
In section: UMass Chan News
In subsection: Articles-old
UMass Medical School - Scientist wins award for tackling devastating brain disease in kids
Scientist wins award for tackling devastating brain disease in kids
Esteves2011 01 10Jim Fessenden UMass Medical School Communications Miguel Sena Esteves, PhD, associate professor of neurology, was presented with the annual “See the Light” award from the Mathew Forbes Romer Foundation in recognition of his leadership in the fight against
Esteves2011 01 10Jim Fessenden UMass Medical School Communications Miguel
Last modified: Nov 12, 2025
-
In section: UMass Chan News
In subsection: Articles
UMass Medical School - Collaboration to advance therapy for Huntington’s Disease
Collaboration to advance therapy for Huntington’s Disease
Alison Duffy
UMass Medical School Communications
Neil Aronin UMass Medical School has entered into a research collaboration with pharmaceutical company Lundbeck Inc. aimed at further development of a targeted therapy to slow or halt the progression of Huntington’s disease (HD). Led by Neil Aronin, MD, professor of medicine, cell biology and physiology, the collaboration
Last modified: Dec 17, 2013